lanreotide and its Impurities

Lanreotide is used in adults to treat: acromegaly that cannot be treated with surgery or radiation carcinoid syndrome. It is marketed under the trade name Somatuline.Reference standards of Lanreotide API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 12 results for lanreotide Impurities
Drug Reference Standards & Impurity Synthesis in India
PA STI 056001

Lanreotide-d8

Lanreotide-d8

  • Catalogue No.:PA STI 056001

  • CAS :

    NA

  • Molecular Formula : C54H61D8N11O10S2

  • Molecular Weight : 1104.37

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 1690000

Lanreotide

Lanreotide

  • Catalogue No.:PA 12 1690000

  • CAS :

    108736-35-2

  • Molecular Formula : C54H69N11O10S2

  • Molecular Weight : 1096.33

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 1691000

((4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)-L-threonine

((4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)-L-threonine

  • Catalogue No.:PA 12 1691000

  • CAS :

    150155-56-9

  • Molecular Formula : C54H68N10O11S2

  • Molecular Weight : 1097.32

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 1691001

N-Ac-Lanreotide

N-Ac-Lanreotide

  • Catalogue No.:PA 12 1691001

  • CAS :

    109605-17-6

  • Molecular Formula : C56H71N11O11S2

  • Molecular Weight : 1138.37

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA PEP 001122

(4R,7S,10S,13R,16S,19R)-19-((R)-2-Amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-13-((1-nitroso-1H-indol-3-yl)methyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide

(4R,7S,10S,13R,16S,19R)-19-((R)-2-Amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-13-((1-nitroso-1H-indol-3-yl)methyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide

  • Catalogue No.:PA PEP 001122

  • CAS :

    NA

  • Molecular Formula : C54H68N12O11S2

  • Molecular Weight : 1125.33

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA PEP 001129

(S)-6-Amino-2-((S)-2-((S)-2-((R)-2-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-3-mercaptopropanamido)-3-(4-hydroxyphenyl)propanamido)-3-(1H-indol-3-yl)propanamido)-N-((S)-1-((3-(((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)amino)-3-oxoprop-1-en-2-yl)amino)-3-methyl-1-oxobutan-2-yl)hexanamide

(S)-6-Amino-2-((S)-2-((S)-2-((R)-2-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-3-mercaptopropanamido)-3-(4-hydroxyphenyl)propanamido)-3-(1H-indol-3-yl)propanamido)-N-((S)-1-((3-(((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)amino)-3-oxoprop-1-en-2-yl)amino)-3-methyl-1-oxobutan-2-yl)hexanamide

  • Catalogue No.:PA PEP 001129

  • CAS :

    NA

  • Molecular Formula : C54H69N11O10S

  • Molecular Weight : 1064.27

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA PEP 001130

(3R,6S,9S,12S,15S,18R)-12-((1H-Indol-3-yl)methyl)-18-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-9-(4-aminobutyl)-15-(4-hydroxybenzyl)-6-isopropyl-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentaazacyclononadecane-3-carboxamide

(3R,6S,9S,12S,15S,18R)-12-((1H-Indol-3-yl)methyl)-18-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-9-(4-aminobutyl)-15-(4-hydroxybenzyl)-6-isopropyl-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentaazacyclononadecane-3-carboxamide

  • Catalogue No.:PA PEP 001130

  • CAS :

    NA

  • Molecular Formula : C54H69N11O10S

  • Molecular Weight : 1064.27

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA PEP 001131

(4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide 1-oxide

(4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide 1-oxide

  • Catalogue No.:PA PEP 001131

  • CAS :

    NA

  • Molecular Formula : C54H69N11O11S2

  • Molecular Weight : 1112.33

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA PEP 001132

(4R,7S,10S,13R,16S,19R)-19-((R)-2-Amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-13-((2-oxoindolin-3-yl)methyl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide

(4R,7S,10S,13R,16S,19R)-19-((R)-2-Amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-13-((2-oxoindolin-3-yl)methyl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide

  • Catalogue No.:PA PEP 001132

  • CAS :

    NA

  • Molecular Formula : C54H69N11O11S2

  • Molecular Weight : 1112.33

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA PEP 001201

D-Cys-7 Lanreotide

D-Cys-7 Lanreotide

  • Catalogue No.:PA PEP 001201

  • CAS :

    205234-53-3

  • Molecular Formula : C54H69N11O10S2

  • Molecular Weight : 1096.33

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA PEP 001202

N-Ac-Lanreotide Trifluoroacetate Salt

N-Ac-Lanreotide Trifluoroacetate Salt

  • Catalogue No.:PA PEP 001202

  • CAS :

    NA

  • Molecular Formula : C58H72F3N11O13S2

  • Molecular Weight : 1252.39

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA PEP 001203

Lys-(Ac)5 Lanreotide Trifluoroacetate Salt

Lys-(Ac)5 Lanreotide Trifluoroacetate Salt

  • Catalogue No.:PA PEP 001203

  • CAS :

    NA

  • Molecular Formula : C58H72F3N11O13S2

  • Molecular Weight : 1252.39

Enquire
Details
Periodic Table- Pharmaffiliates

Calculators
Periodic Table- Pharmaffiliates

Contact us

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help
pharmaffiliates